MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
attributable to common...
-$6,610K
Unrealized (loss) gain on
available-for-sale securities
$1K
Net loss
-$6,611K
Other income, net
$263K
Loss from operations
-$6,874K
Total operating
expenses
$6,874K
General and
administrative
$4,049K
Research and development
$2,825K
Back
Back
Income Statement
source: myfinsight.com
Athira Pharma, Inc. (ATHA)
Athira Pharma, Inc. (ATHA)